Literature DB >> 3643160

The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers.

K Krogsgaard, B O Lindhardt, J O Nielson, P Andersson, P Kryger, J Aldershvile, J Gerstoft, C Pedersen.   

Abstract

The presence of antibodies to HTLV-III and markers of active hepatitis B virus replication was examined in a longitudinal study of 33 consecutive male homosexual HBsAg carriers. The mean follow-up time was 37 months (range = 4 to 109 months). All patients were initially hepatitis B virus DNA-positive and HBeAg positive. Antibodies to HTLV-III were detectable in eight patients while they were positive for both of these markers. One of them cleared hepatitis B virus DNA and seroconverted from HBeAg to anti-HBe. This corresponds to an annual clearance/seroconversion rate of 4% (95% confidence limits = 0 to 15%). In two patients, antibodies to HTLV-III appeared after clearance of hepatitis B virus DNA and HBeAg, and in one of them, hepatitis B virus DNA reappeared. Among the 25 patients negative for HTLV-III antibodies, the annual hepatitis B virus DNA clearance rate was 20% and HBeAg to anti-HBe seroconversion rate was 11% (95% confidence limits = 11 to 31% and 4 to 20% respectively). The observed hepatitis B virus DNA clearance rates in the two groups were significantly different (p less than 0.05). Disease activity, as determined by transaminase levels, was significantly lower in HTLV-III-infected individuals as compared to individuals without HTLV-III infection (p less than 0.05). Infection with HTLV-III may extend the period of active viral replication or even reactivate hepatitis B virus replication and seems to diminish inflammatory disease activity in chronic HBsAg carriers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3643160     DOI: 10.1002/hep.1840070109

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Authors:  E Bierhoff; H P Fischer; E Willsch; J Rockstroh; U Spengler; H H Brackmann; J Oldenburg
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection.

Authors:  B Vandercam; C Cornu; J L Gala; A Geubel; M Cahill; M E Lamy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

Review 3.  Sexually transmitted hepatitis: a review.

Authors:  R J Gilson
Journal:  Genitourin Med       Date:  1992-04

4.  Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.

Authors:  G Garcia; A Smedile; K F Bergmann; J L Gerin; P B Gregory; T C Merigan; W S Robinson
Journal:  West J Med       Date:  1990-07

5.  Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.

Authors:  John Weiser; Alejandro Perez; Heather Bradley; Hope King; R Luke Shouse
Journal:  Ann Intern Med       Date:  2017-12-26       Impact factor: 25.391

6.  Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India.

Authors:  A Risbud; S Mehendale; S Basu; S Kulkarni; A Walimbe; V Arankalle; R Gangakhedkar; A Divekar; R Bollinger; D Gadkari; R Paranjape
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

Review 7.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

8.  HBV, HDV and HIV infections in 242 drug addicts: two-year follow-up.

Authors:  C Mandelli; M Cesana; P Ferroni; G P Lorini; G P Aimo; A Tagger; P A Bianchi; D Conte
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

9.  Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection.

Authors:  R D Goldin; D E Fish; A Hay; J A Waters; M J McGarvey; J Main; H C Thomas
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

10.  Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania.

Authors:  Tumaini J Nagu; Muhammad Bakari; Mecky Matee
Journal:  BMC Public Health       Date:  2008-12-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.